Comparison of a Markov Cohort Model and a Discrete-Event Simulation for Economic Analyses of Treatments for Multiple Sclerosis

Value in Health ◽

10.1016/j.jval.2014.08.901 ◽

2014 ◽

Vol 17 (7) ◽

pp. A398

Author(s):

A. Kansal ◽

A. Tafazzoli ◽

R. Leipold ◽

S. Sarda

Keyword(s):

Multiple Sclerosis ◽

Discrete Event Simulation ◽

Discrete Event ◽

Cohort Model ◽

Event Simulation ◽

Economic Analyses

Download Full-text

About the advantages and disadvantages of discrete-event simulation for health economic analyses

Expert Review of Pharmacoeconomics & Outcomes Research ◽

10.1080/14737167.2016.1259572 ◽

2016 ◽

Vol 16 (6) ◽

pp. 651-652

Author(s):

Mondher Toumi ◽

Ekkehard Beck ◽

Steve Sherman ◽

Leyla Mohseninejad ◽

Samuel Aballéa

Keyword(s):

Health Economic ◽

Discrete Event Simulation ◽

Discrete Event ◽

Event Simulation ◽

Advantages And Disadvantages ◽

Economic Analyses

Download Full-text

Modeling The Natural History of Secondary-Progressive Multiple Sclerosis: A New Modeling Approach Using Discrete Event Simulation

Value in Health ◽

10.1016/j.jval.2015.09.2617 ◽

2015 ◽

Vol 18 (7) ◽

pp. A700 ◽

Author(s):

L Hernandez ◽

S Guo ◽

A Altincatal ◽

S Naoshy ◽

C Watson

Keyword(s):

Multiple Sclerosis ◽

Natural History ◽

Discrete Event Simulation ◽

Discrete Event ◽

Progressive Multiple Sclerosis ◽

Secondary Progressive Multiple Sclerosis ◽

Event Simulation ◽

Secondary Progressive ◽

Modeling Approach ◽

Download Full-text

Advantages and disadvantages of discrete-event simulation for health economic analyses

Expert Review of Pharmacoeconomics & Outcomes Research ◽

10.1586/14737167.2016.1165608 ◽

2016 ◽

Vol 16 (3) ◽

pp. 327-329 ◽

Author(s):

J. Jaime Caro ◽

Jörgen Möller

Keyword(s):

Health Economic ◽

Discrete Event Simulation ◽

Discrete Event ◽

Event Simulation ◽

Advantages And Disadvantages ◽

Economic Analyses

Download Full-text

Predicting the long-term clinical effectiveness of daclizumab in relapsing-remitting multiple sclerosis: A new modeling framework using discrete event simulation

Value in Health ◽

10.1016/j.jval.2013.03.478 ◽

2013 ◽

Vol 16 (3) ◽

pp. A101 ◽

Author(s):

S. Guo ◽

L. Hernandez ◽

C. Saint-Laurent Thibault ◽

I. Proskorovsky ◽

G.A. Phillips

Keyword(s):

Multiple Sclerosis ◽

Discrete Event Simulation ◽

Discrete Event ◽

Clinical Effectiveness ◽

Modeling Framework ◽

Event Simulation ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

An Empirical Comparison Of A Markov Cohort Model And A Discrete Event Simulation For Cost-Effectiveness Analysis In Orthopaedics

Value in Health ◽

10.1016/j.jval.2014.03.023 ◽

2014 ◽

Vol 17 (3) ◽

pp. A4

Author(s):

L.B. Standfield ◽

T. Comans ◽

P.A. Scuffham

Keyword(s):

Cost Effectiveness ◽

Discrete Event Simulation ◽

Discrete Event ◽

Cost Effectiveness Analysis ◽

Cohort Model ◽

Empirical Comparison ◽

Event Simulation ◽

Effectiveness Analysis

Download Full-text

Cost-Utility of Fingolimod Compared With Dimethyl Fumarate (Dmf) In Highly Active Relapsing Remitting Multiple Sclerosis (Rrms) In England: Comparison of A Markov and Discrete Event Simulation Model

Value in Health ◽

10.1016/j.jval.2015.09.2476 ◽

2015 ◽

Vol 18 (7) ◽

pp. A759 ◽

Author(s):

J Kusel ◽

M Maruszczak ◽

N Adlard

Keyword(s):

Multiple Sclerosis ◽

Discrete Event Simulation ◽

Discrete Event ◽

Dimethyl Fumarate ◽

Cost Utility ◽

Event Simulation ◽

Discrete Event Simulation Model ◽

Highly Active ◽

Relapsing Remitting ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Reply: Letter to the Editor: About the advantages and disadvantages of discrete-event simulation for health economic analyses

Expert Review of Pharmacoeconomics & Outcomes Research ◽

10.1080/14737167.2016.1259573 ◽

2016 ◽

Vol 16 (6) ◽

pp. 653-653

Author(s):

J. Jaime Caro ◽

Jörgen Möller

Keyword(s):

Health Economic ◽

Discrete Event Simulation ◽

Discrete Event ◽

Event Simulation ◽

Advantages And Disadvantages ◽

Letter To The Editor ◽

Economic Analyses

Download Full-text

A discrete event simulation to model the cost-utility of fingolimod and natalizumab in rapidly evolving severe relapsing-remitting multiple sclerosis in the UK

Journal of Medical Economics ◽

10.1080/13696998.2016.1276070 ◽

2017 ◽

Vol 20 (5) ◽

pp. 474-482 ◽

Author(s):

Stephen M. Montgomery ◽

Maciej J. Maruszczak ◽

David Slater ◽

Jeanette Kusel ◽

Richard Nicholas ◽

...

Keyword(s):

Multiple Sclerosis ◽

Discrete Event Simulation ◽

Discrete Event ◽

Cost Utility ◽

Event Simulation ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

The Uk ◽

The Cost ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Human systems integration: A discrete event simulation of operational utility for control of multiple small unmanned aerial systems

PsycEXTRA Dataset ◽

10.1037/e578862012-006 ◽

2010 ◽

Author(s):

John M. Colombi ◽

Jill R. Ward

Keyword(s):

Discrete Event Simulation ◽

Discrete Event ◽

Systems Integration ◽

Unmanned Aerial Systems ◽

Event Simulation ◽

Human Systems Integration ◽

Aerial Systems ◽

Download Full-text

Healthcare Operations Improvement with an Integration of Discrete-Event Simulation and Lean Thinking

International conference on Innovative Engineering Technologies (ICIET’2014) Dec. 28-29, 2014 Bangkok (Thailand) ◽

10.15242/iie.e1214018 ◽

2014 ◽

Keyword(s):

Discrete Event Simulation ◽

Discrete Event ◽

Healthcare Operations ◽

Lean Thinking ◽

Event Simulation

Download Full-text